✦ LIBER ✦
Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas
✍ Scribed by A. Tosoni; E. Franceschi; M. Ermani; R. Bertorelle; L. Bonaldi; V. Blatt; Alba A. Brandes
- Publisher
- Springer US
- Year
- 2008
- Tongue
- English
- Weight
- 270 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.